Suzhou Basecare Medical (HKG:2170) obtained approval for the renewal of the registration certificate of its PGT-A kit for five years from China's National Medical Products Administration in October, a Wednesday bourse filing said.

The renewed registration certificate is valid till Feb. 20, 2030.

The PGT-A kit is used to accurately detect the DNA of blastocyst trophoblast cells and analyze the potential existence of any abnormalities of aneuploidy in embryos.

Shares of the genetic technology researching company closed nearly 10% higher on Wednesday.

Price (HKD): $2.81, Change: $+0.25, Percent Change: +9.77%